Zobrazeno 1 - 10
of 44
pro vyhledávání: ''
Autor:
Ichiro Oda, Noriaki Hasuike, Manabu Muto, Shinichiro Hori, Hiroshi Katayama, Masanori Terashima, Kingo Hirasawa, Masahiro Nakagawa, Kohei Takizawa, Yasumasa Niwa, Narikazu Boku, Gakuto Ogawa, Satoshi Tanabe, Ryoji Kushima, Keiko Minashi, Junko Fujisaki, Ryu Ishihara, Tomonori Yano, Hiroyuki Ono, Atsuo Takashima, Haruhiko Fukuda, Yoshinobu Yamamoto, Hisashi Doyama
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 24(2)
While endoscopic submucosal dissection (ESD) is recognized as a minimally invasive standard treatment for differentiated early gastric cancers (EGCs), it has not been indicated for undifferentiated EGC (UD-EGC) because of a relatively high risk of ly
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 24(4)
Gastric cancer remains one of the 3 most common causes of cancer death worldwide. Understanding the health and economic factors that affect screening cost-effectiveness in different countries will help address when and where it makes most sense to sc
Autor:
Shusuke Haruta, Masaki Ueno, Yusuke Ogawa, Akikazu Yago, Yosuke Hamada, Harushi Udagawa, Yu Ohkura, Masayuki Urabe
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 24(3)
Surveillance after curative surgery for gastric cancer is conventionally performed for 5 years. However, the appropriate follow-up period remains controversial. This study retrospectively compiled a clinicopathological database of patients who underw
Autor:
Katsumi Yamamoto, Waku Hatta, Tetsuya Sumiyoshi, Tatsuya Mikami, Mikitaka Iguchi, Tsutomu Nishida, Hisashi Doyama, Jun Nishikawa, Kimihiro Igarashi, Yoichi Hiasa, Kazuya Kitamura, Takuya Inoue, Koichiro Kawaguchi, Takuto Hikichi, Hideomi Tomida, Shiko Kuribayashi, Kazuki Sumiyama, Toshio Uraoka, Ichiro Oda, Atsushi Yanagitani, Yosuke Tsuji, Yoshinori Morita, Kenkei Hasatani, Tomoyuki Yada, Mitsuhiro Fujishiro, Tomoki Fujita, Toshiyuki Yoshio
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 24(1)
Delayed bleeding after gastric endoscopic submucosal dissection (ESD) in patients receiving anticoagulants remains an unpreventable adverse event. Although direct-acting oral anticoagulants (DOACs) have superior efficacy in preventing thromboembolism
Autor:
Yoshiyuki Fujiwara, Hiraku Kumamaru, Akira Tsuburaya, Hiroaki Miyata, Yuko Kitagawa, Hiroyuki Konno, Masanori Terashima, Keiichi Fujiya, Yasuhiro Kodera
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 24(1)
Postoperative intra-abdominal infectious complication (PIIC) after gastrectomy for gastric cancer worsens in-hospital death or long-term survival. However, the methodology for PIIC preoperative risk assessment remains unestablished. We aimed to devel
Autor:
Ryohei Kawabata, Yuichiro Doki, Kotaro Yamashita, Makoto Yamasaki, Hidetoshi Eguchi, Yukinori Kurokawa, Hiroshi Imamura, Atsushi Takeno, Junya Fujita, Tsuyoshi Takahashi
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 23(5)
Several studies have shown that postoperative complications worsen the prognosis of patients with malignancies. However, our previous study showed that C-reactive protein (CRP) elevation over 12 mg/dL was a more reliable prognostic indicator than com
Autor:
Hidenobu Matsushita, Mitsuro Kanda, Kenta Murotani, Yasuhiro Kodera, Koki Nakanishi, Takahiro Asada, Kiyoshi Ishigure, Yoshinari Mochizuki, Seiji Ito, Hitoshi Teramoto, Chie Tanaka, Toshifumi Murai, Daisuke Kobayashi, Michitaka Fujiwara, Akiharu Ishiyama, Dai Shimizu
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 23(4)
Few well-controlled studies have compared postoperative complications between Billroth I (B-I) and Roux-en-Y (R-Y). The aim of the present study was to compare the incidence of overall and severe postoperative complications by reconstruction method a
Autor:
Sho Otsuki, Shinji Morita, Takaki Yoshikawa, Hitoshi Katai, Yukinori Yamagata, Toshirou Nishida, Masahiro Yura
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 23(2)
Whether or not surgery alone is sufficient for treating patients with pathological stage T1N2M0 (Stage IIA), T1N3a/bM0 (Stage IIB/IIIB), and T3N0M0 (Stage IIA) gastric cancer who were not indicated for adjuvant treatment according to the Japanese gas
Autor:
Isao Miyashiro, Takashi Ishikawa, Takeo Fukagawa, Souya Nunobe, Hiroyuki Ono, Kohei Akazawa, Satoshi Suzuki, Yoh Isobe, Yoshihiro Kakeji, Ichiro Oda, Shunichi Tsujitani, Hitoshi Katai, Satoshi Tanabe
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 23(2)
The proportion of elderly patients undergoing surgery for gastric cancer is increasing. However, limited number of therapeutic outcomes in the elderly has been reported. Here we examined the surgical results based on a nationwide survey of elderly pa
Autor:
Keiko Minashi, Nozomu Machida, Kensei Yamaguchi, Masahiro Goto, Shuichi Hironaka, Daisuke Takahari, Keisho Chin, Atsuo Takashima, Tomohiro Nishina, Naoki Ishizuka, Takeru Wakatsuki, Kenji Amagai, Takako Eguchi Nakajima, Shigenori Kadowaki, Narikazu Boku, Keisei Taku, Hirokazu Shoji
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 22(6)
Trastuzumab with cisplatin and fluoropyrimidines improves overall survival (OS) in patients with HER2-positive advanced gastric cancer (AGC). S-1 plus oxaliplatin (SOX) is one of the standard regimens for HER2-negative AGC in Japan. However, few stud